ADARx Pharmaceuticals, Inc. (ADRX)
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXIndustrials · Specialty Business Services
-0.28%$17.63
AH Close$17.63+0.00%vs close
AH Close$17.63+0.00%vs close
Mkt Cap$1.88B
Float52.5M
O/S106.8M
Inst Own-
SI2.2%
Dilution
Delisting Issues Timeline
Financials Summary
No financial data available.
Debt & Equity
No debt & equity data available.
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in ADRX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
No balance sheet details available.
Income Statement
No income statement data available.
Balance Sheet
No balance sheet data available.
Cash Flow Statement
No cash flow data available.